Search results
New weight loss drugs are coming, and they could burn more fat with fewer side effects
NBC News via Yahoo News· 2 days agoThe drug could be approved in China in 2025, Ji said. Improving metabolic conditions An estimated...
DURECT (NASDAQ:DRRX) Shares Pass Above 200 Day Moving Average of $0.98
ETF DAILY NEWS· 18 hours agoDURECT Co. (NASDAQ:DRRX – Get Free Report) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $0.98 and traded as high as $1.60. DURECT ...
Altimmune stock price is still at risk despite Pemvidutide hopes | Invezz
Invezz· 2 days agoAltimmune (NASDAQ: ALT) stock price drifted upwards on Monday amid optimism that it will become a...
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Akero...
Morningstar· 1 day agoPomerantz LLP announces that a class action lawsuit has been filed against Akero Therapeutics, Inc. ("Akero" or the "Company") (NASDAQ: AKRO). Such investors are advised to contact Danielle ...
Why Wall Street Is Chasing Ozempic Wannabes
The Wall Street Journal· 5 days agoBut over the next two days, the shares gave it all back, largely thanks to Gilead itself. The company told analysts its program is focused on treatments...
Deadline in 2 Days: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Class Action...
Morningstar· 2 days agoThe law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Northern ...
Madrigal Pharmaceuticals senior VP sells $532,000 in stock By Investing.com
Investing.com· 6 days agoIn a recent transaction on June 14, Robert E. Waltermire, Senior Vice President and Chief of...
TUESDAY DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Akero Therapeutics, Inc. Investors...
Morningstar· 2 days agoSAN DIEGO, June 23, 2024 (GLOBE NEWSWIRE) -- The law firm of Robbins Geller Rudman & Dowd LLP announces that purchasers of Akero Therapeutics, Inc. (NASDAQ: AKRO) common stock between September 13, 2022 and October 9, 2023, all dates inclusive (the
RVW Wealth LLC Decreases Stock Position in CohBar, Inc. (NASDAQ:CWBR)
ETF DAILY NEWS· 6 days agoRVW Wealth LLC cut its stake in CohBar, Inc. (NASDAQ:CWBR – Free Report) by 96.7% in the first quarter, according to the company in its most recent disclosure with the Securities and Exchange ...
AKRO INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Akero Therapeutics, Inc....
Benzinga· 7 days agoAttorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Akero Therapeutics, Inc. ( ...
